International (Africa)
Funding Controversy Adds To Difficulties in South Africa
Published in AIDS Weekly, March 25th, 1996
The scandal is arguably the most visible of the problems that have plagued the anti-HIV effort. It erupted when news broke that $3.6 million had been spent on Sarafina II, a two-hour anti-AIDS play described by its detractors as a farce.
Critics, who include the ruling African National Congress' Women's League, say the play denigrates women and, targets only black youths in townships, has a few garbled messages about AIDS and has so far been seen by just 5,000 of South Africa's 41 million...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1996-03-25)
More Articles from AIDS Weekly
- Conference Coverage (NCVDG)
HIVIG Given During Primary HIV Infection Could Prevent Disease - Conference Coverage (NCVDG)
Heterosexual AIDS Epidemic Could Expand in U.S., Europe - Conference Coverage (NCVDG)
Targeted Lymph Node Immunization Protects Against Rectal Challenge - AIDS Therapies (Immunology)
Drug May Increase Long-Term Survival in HIV Disease - AIDS Therapies (MDX-240)
AIDS Product Shows Promise in Phase I/II Clinical Study - Antisense Technology (HIV)
Nicked Dumbbell Oligonucleotides Shows Increased Nuclease Resistance - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
